Distraction Osteogenesis Devices Market Share

Distraction Osteogenesis Devices Market Overview 

Distraction Osteogenesis Devices Market Segment Insights

The distraction osteogenesis devices market has been segmented into device type, age, application, and end-user.

Distraction Osteogenesis Device Type Insights

The market, based on device type, has been segmented into mandibular distraction devices, palatal distraction devices, alveolar distraction devices, craniofacial distraction devices, Lefort distraction devices, small bone distraction devices, and others. The market, based on craniofacial distraction devices, has been further segmented into external and internal distractors. The market, based on external distractors is further classified into unidirectional distractors, bidirectional distractors, and multiplanar distractors whereas the market, based on, internal distractors can be classified into tooth-borne distractors, bone-borne distractors, and hybrid distractors. 

Distraction Osteogenesis Devices Age Insights

The market, by age, has been segmented into pediatrics and adults. 

Distraction Osteogenesis Devices Appllication Insights

The market, by application, has been segmented into dentistry, podiatry, orthopedics, and others. 

Distraction Osteogenesis Devices End-user Insights

The market, by end-user, has been segmented into hospitals, orthopedic clinics, and others.

Key players

Some of the key players in the global distraction osteogenesis devices market are:

• Johnson & Johnson Services, Inc.


• Zimmer Biomet Holdings, Inc.


• Stryker Corporation


• KLS Martin Group


• Osteomed, Acumed LLC


• Jeil Medical Corporation


• Ningbo Cibei Medical Treatment Appliance Co., Ltd. 


• Ortho Max Manufacturing Company Pvt. Ltd.


• Ortho Care 


• Titamed 

Distraction Osteogenesis Devices market Regional Analysis

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The distraction osteogenesis devices market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European distraction osteogenesis devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.

Geographically, North America is expected to dominate the global distraction osteogenesis devices market owing to increasing number of procedures for treating facial abnormalities in the US. Also, most of the key players have their research and development teams working in this field in the US which in turn increases the awareness among the people about the technique in this region.

The European market is expected to be the second-largest due to increase in initiatives taken by public and private organizations in this field.

Moreover, the market in Asia-Pacific is predicted to be the fastest-growing during the assessment period owing to the expansion of the prominent players along with setting the subsidiaries in these markets.

The market in the Middle East & Africa is likely to account for the smallest share of the global market.

Distraction Osteogenesis Devices Device Market Segmentation

Distraction Osteogenesis Devices Device Type Outlook

• Mandibular Distraction Devices


• Palatal Distraction Devices


• Alveolar Distraction Devices


• Craniofacial Distraction Devices




• Internal Distractors




• Tooth-borne Distractors


• Bone-Borne Distractors


• Hybrid Distractors




• External Distractors




• Unidirectional Distractors


• Bidirectional Distractors


• Multiplanar Distractors




• LeFort Distraction Devices


• Small Bone Distraction Devices


• Others

Distraction Osteogenesis Devices Age Outlook

• Pediatrics


• Adults

Distraction Osteogenesis Devices End-User Outlook

• Hospitals


• Orthopedic Clinics


• Others

Distraction Osteogenesis Devices Regional Outlook

• Americas
  
  
  
  • North America
    
    
    
    • US
    
    
    • Canada
    
    
    • South America
    
    
    
    
  
  
  
  


• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• The Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

May 2018:DePuy Synthes, a division of Johnson & Johnson Medical Devices, announced an exclusive agreement in the United States with Prosidyan to promote the Fibergraft family of synthetic bone graft materials, which are ultra-porous, designed for ease of use, and engineered for optimal resorption in clinical use during spine fusion surgery. DePuy Synthes' portfolio of biomaterials and distractors will be considerably enhanced with the addition of Fibergraft. At the American Academy of Orthopaedic Surgeons' annual meeting in August 2018, Stryker Corp. announced the launch of the Pivot Guardian, the first-ever post-free hip distraction device. This gadget was created to help patients avoid groin problems after hip arthroscopy.

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report